Aids Vaccine Research Inst is categorized under Noncommercial Research Organizations in Glenmont, NY and active since 2001.
Aids Vaccine Research Inst was established in 2001, and today employs 1 to 4, earning Unknown per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Arlene Ransinch at the company’s single location by writing to 34 Placid Lane, Glenmont, New York NY 12077 or by phoning (518) 439-5379. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Aids Vaccine Research Inst |
| Contact Person: | Arlene Ransinch |
| Address: | 34 Placid Lane, Glenmont, New York 12077 |
| Phone Number: | (518) 439-5379 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Research Organizations |
| SIC Code: | 8733 |
| NAICS Code: | 5419100 |
| Share This Business: |
Aids Vaccine Research Inst was started in 2001 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Arlene Ransinch for inquiries that concern Aids Vaccine Research Inst by calling the company number (518) 439-5379, as your correspondence is most welcome. Additionally, the physical location of the single location of Aids Vaccine Research Inst can be found at the coordinates 42.589814,-73.803822 as well as the street address 34 Placid Lane in Glenmont, New York 12077.
For its online presence, you may visit Aids Vaccine Research Inst’s website at and engage with its social media outlets through on Twitter and on Facebook.